← Open Payments lookup

JEFFREY HUGHES: Open Payments

NPI 1841799616 · BELZONI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$665 in 20 payments from 8 companies in 2025. Trend: 2023 $631 · 2024 $558 · 2025 $665

Food & beverage: $665
CompanyPaymentsAmount
Novo Nordisk Inc6$285
AstraZeneca Pharmaceuticals LP4$148
Lundbeck LLC5$118
ABBVIE INC.1$25
GlaxoSmithKline, LLC.1$24
Amgen Inc.1$23
Esperion Therapeutics, Inc.1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$20

Products named: Ozempic, AIRSUPRA, REXULTI, Rybelsus, VRAYLAR, TRELEGY ELLIPTA, OTEZLA, NEXLETOL.

Industry payments across MS — which companies pay providers there.